Keyword: Avara Pharmaceutical Services
Novartis is expected to soon regain control of the Sandoz Boucherville sterile drug manufacturing site in Canada that it sold to Avara last year.
When AstraZeneca sold its Avlon, England plant in 2016, it thought its liabilities were over. Former employees said the drugmaker broke its promises.
A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy.
Contract manufacturer Avara is taking advantage of Sandoz's slimdown efforts by buying a sterile manufacturing plant in Quebec.
Budding CDMO Avara Pharmaceutical Services has bought a solid dose facility in France from AstraZeneca, its third plant acquisition in three months.
GlaxoSmithKline has a deal to sell a consumer health products plant in the U.S. to CDMO Avara Pharmaceutical Services.
A two-year-old CDMO that has created its manufacturing network snapping up unwanted plants is buying a former Hospira sterile plant from Pfizer.
U.S. CMO Avara Pharmaceutical Services has struck a deal to buy a plant in the U.K. that AstraZeneca was set to close, saving more than 200 jobs in the process.